Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis

被引：0
|
作者：
Marissa K. Srour
Joshua Tseng
Michael Luu
Rodrigo F. Alban
Armando E. Giuliano
Alice Chung
机构：
[1] Cedars-Sinai Medical Center,Division of Surgical Oncology, Department of Surgery
[2] Cedars-Sinai Medical Center,Department of Biostatistics and Bioinformatics
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3305 / 3311
页数：6
相关论文
共 50 条
  • [21] Axillary nodal management following neoadjuvant chemotherapy for node-positive breast cancer
    Ponce, Carolina
    Loza, Martin
    Mando, Pablo
    Pineiro, Africa
    Amat, Mora
    Costanzo, Victoria
    Nervo, Adrian
    Mysler, Daniel
    Nadal, Jorge
    Colo, Federico
    Loza, Jose
    Chacon, Reinaldo
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 437 - 438
  • [22] Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer
    Kim, Rihyeon
    Chang, Jung Min
    Lee, Han-Byoel
    Lee, Su Hyun
    Kim, Soo-Yeon
    Kim, Eun Sil
    Cho, Nariya
    Moon, Woo Kyung
    RADIOLOGY, 2019, 293 (01) : 49 - 57
  • [23] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Khan, Tahsin M.
    Rossi, Alexander J.
    Suman, Vera
    Haffty, Bruce
    Hernandez, Jonathan M.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1526 - 1527
  • [24] Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
    Stafford, Arielle
    Williams, Austin
    Edmiston, Kirsten
    Cocilovo, Costanza
    Cohen, Robert
    Bruce, Sara
    Yoon-Flannery, Kahyun
    De La Cruz, Lucy
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4669 - 4677
  • [25] Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
    Arielle Stafford
    Austin Williams
    Kirsten Edmiston
    Costanza Cocilovo
    Robert Cohen
    Sara Bruce
    Kahyun Yoon-Flannery
    Lucy De La Cruz
    Annals of Surgical Oncology, 2020, 27 : 4669 - 4677
  • [26] Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer
    Vila, Jose
    Mittendorf, Elizabeth A.
    Farante, Gabriel
    Bassett, Roland L.
    Veronesi, Paolo
    Galimberti, Viviana
    Peradze, Nicolas
    Stauder, Michael C.
    Chavez-MacGregor, Mariana
    Litton, Jennifer F.
    Huo, Lei
    Kuerer, Henry M.
    Hunt, Kelly K.
    Caudle, Abigail S.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3501 - 3509
  • [27] Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer
    Jose Vila
    Elizabeth A. Mittendorf
    Gabriel Farante
    Roland L. Bassett
    Paolo Veronesi
    Viviana Galimberti
    Nicolas Peradze
    Michael C. Stauder
    Mariana Chavez-MacGregor
    Jennifer F. Litton
    Lei Huo
    Henry M. Kuerer
    Kelly K. Hunt
    Abigail S. Caudle
    Annals of Surgical Oncology, 2016, 23 : 3501 - 3509
  • [28] Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Tahsin M. Khan
    Alexander J. Rossi
    Vera Suman
    Bruce Haffty
    Jonathan M. Hernandez
    Judy C. Boughey
    Annals of Surgical Oncology, 2022, 29 : 1526 - 1527
  • [29] Validity of omission of axillary lymph node dissection after neoadjuvant chemotherapy for node-positive primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Tsukahara, Daisuke
    Jinno, Hiromitsu
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Nomogram Predicting Axillary Lymph Node Dissection Omission After Neoadjuvant Chemotherapy for Node-positive Breast Cancer
    Seki, Hirohito
    Ishiguro, Yuki
    Makino, Akitsugu
    Yamaguchi, Kei
    Imoto, Shigeru
    ANTICANCER RESEARCH, 2024, 44 (11) : 5131 - 5138
12345